| |
CHD Patients with Diabetes (n = 115)
|
CHD Patients without Diabetes (n = 97)
|
|---|
|
Age(yr)
|
67.1 ± 9.7
|
63.7 ± 8.3
|
|
Female/Male
|
45/70
|
53/44
|
|
SBP(mmHg)
|
135.2 ± 20.6
|
130.8 ± 17.7
|
|
DBP(mmHg)
|
77.6 ± 8.4
|
75.7 ± 7.5
|
|
BMI(kg/m
2
)
|
25.0 ± 2.6
|
24.3 ± 2.1
|
|
Waist (cm)
|
92.4 ± 8.6
|
88.1 ± 7.8†
|
|
Hip (cm)
|
94.2 ± 6.4
|
93.1 ± 5.7
|
|
WHR
|
0.98 ± 0.1
|
0.94 ± 0.1†
|
|
Gensini Score
|
53.7 ± 9.2
|
22.9 ± 6.3†
|
|
FPG(mmol/L)
|
9.0 ± 1.2
|
5.2 ± 0.6‡
|
|
TG(mmol/L)
|
2.2 ± 0.5
|
1.8 ± 0.6*
|
|
TC(mmol/L)
|
4.4 ± 1.1
|
3.9 ± 1.0*
|
|
LDL-C(mmol/L)
|
3.4 ± 1.0
|
2.7 ± 0.7†
|
|
HDL-C(mmol/L)
|
1.0 ± 0.2
|
1.3 ± 0.2†
|
|
ApoA-I(g/L)
|
1.1 ± 0.2
|
1.3 ± 0.3*
|
|
ApoB-100(g/L)
|
0.8 ± 0.2
|
0.6 ± 0.2*
|
|
ApoB-100/A-I
|
0.7 ± 0.2
|
0.5 ± 0.1*
|
|
Preβ
1
-HDL(mg/L)
|
92.0 ± 9.5
|
83.0 ± 7.0
|
|
HDL
3c
(mg/L)
|
83.9 ± 7.4
|
78.5 ± 6.9
|
|
HDL
3b
(mg/L)
|
170.2 ± 20.9
|
142.5 ± 18.2*
|
|
HDL
3a
(mg/L)
|
310.5 ± 44.7
|
272.5 ± 38.1*
|
|
HDL
2a
(mg/L)
|
190.5 ± 25.8
|
285.9 ± 42.2‡
|
|
HDL
2b+Preβ2-HDL
(mg/L)
|
311.9 ± 52.2
|
389.3 ± 69.5‡
|
- CHD, coronary heart disease; BMI, body mass index; FPG, fasting plasma glucose; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; ApoA-I, apolipoproteinA-I; ApoB-100, apolipoprotein B-100.
- Data are presented as Mean ± S.D.
- *P < 0.05, †P < 0.01, ‡P < 0.001 vs CHD with diabetic patients.
